---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-023584"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T14:35:00.952076+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Oramed appoints Yehuda Reznick as director and audit committee chair effective April 1, 2024

## Summary
- Yehuda Reznick appointed to fill existing board vacancy; also audit committee chair and designated financial expert.
- Reznick, 76, was an audit partner at Kesselman & Kesselman (PwC affiliate) from 1999 to 2014.
- Compensation same as other non-executive directors; standard indemnification agreement expected.
- Currently serves on board of Oravax Medical Inc., an affiliate of Oramed.

## SEC filing metadata
- accession: 0001213900-24-023584
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024023584/0001213900-24-023584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024023584/ea0201979-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-023584
- JSON: https://secwatch.observer/filing/0001213900-24-023584.json
- Plain text: https://secwatch.observer/filing/0001213900-24-023584.txt

## Key facts
- Executive change
  Yehuda Reznick was appointed as director at ORAMED PHARMACEUTICALS INC..
  - Action: appointed
  - Role: director
  source text: On March 12, 2024, Oramed Pharmaceuticals Inc. (the “Company”) appointed Mr. Yehuda Reznick to serve as a director, effective as of April 1, 2024, to fill an existing vacancy on the board of directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000121390024023584/0001213900-24-023584-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.